In 844 tumor patient biopsies, enrolled in nine different studies, the aberrant expression of HOXA13 is significantly associated with poor histological grade, TNM stage and overall survival, suggesting that HOXA13 is a potentially valuable biomarker of poor prognosis and potential therapeutic target for human tumors. Here, HOXA13 is linked to neoplasm.